MiMedx Group Inc. (MDXG)

8.35
NASDAQ : Health Technology
Prev Close 8.87
Day Low/High 8.29 / 8.78
52 Wk Low/High 6.05 / 18.25
Avg Volume 3.17M
Exchange NASDAQ
Shares Outstanding 111.03M
Market Cap 984.88M
EPS 0.10
P/E Ratio 28.61
Div & Yield N.A. (N.A)

Latest News

First Week Of MDXG December 21st Options Trading

Investors in MiMedx Group Inc saw new options begin trading this week, for the December 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

MiMedx Reports Unreviewed First Quarter Revenue Exceeded Upper End Of Its Guidance

COMPANY ANNOUNCES ITS REVENUE GUIDANCE FOR SECOND QUARTER AND INCREASES FULL YEAR REVENUE GUIDANCE

MIMEDX 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors Of Deadline In Class Action Lawsuit Against MiMedx Group Inc. - MDXG

MIMEDX 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors Of Deadline In Class Action Lawsuit Against MiMedx Group Inc. - MDXG

ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until April 25, 2018 to file lead plaintiff applications in securities class action lawsuits against MiMedx Group Inc.

MiMedx To Highlight Efficacy Of Its Allografts In Presentations At SAWC Spring Conference

Breakfast Symposium to Underscore Statistically Significant Evidence of EpiFix® in Healing DFUs and VLUs

Washington Woes Slam Stocks: Cramer's 'Mad Money' Recap (Friday 4/13/18)

Washington Woes Slam Stocks: Cramer's 'Mad Money' Recap (Friday 4/13/18)

President Trump is creating a level of uncertainty that breeds selling. But Jim Cramer has your game plan for next week.

MIMEDX SHAREHOLDER ALERT: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against MiMedx Group Inc. - MDXG

MIMEDX SHAREHOLDER ALERT: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against MiMedx Group Inc. - MDXG

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 25, 2018 to file lead plaintiff applications in securities class action lawsuits against MiMedx Group Inc.

MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® Injectable For The Treatment Of Osteoarthritis Of The Knee

MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® Injectable For The Treatment Of Osteoarthritis Of The Knee

Initiation of Phase 2B Study Follows Quickly After FDA Grants RMAT Designation for Knee OA

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of MiMedx Group Inc. Shareholders And A Lead Plaintiff Deadline Of April 25, 2018

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of MiMedx Group Inc. Shareholders And A Lead Plaintiff Deadline Of April 25, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of MiMedx Group Inc.

MDXG EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving MiMedx Group Inc. And A Lead Plaintiff Deadline Of April 25, 2018

MDXG EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving MiMedx Group Inc. And A Lead Plaintiff Deadline Of April 25, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased MiMedx Group Inc.

MiMedx Announces Expectation To Exceed The $92 Million Top End Of First Quarter Revenue Guidance

MiMedx Announces Expectation To Exceed The $92 Million Top End Of First Quarter Revenue Guidance

Continues to Cooperate with Regulatory Agencies

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of MiMedx Group Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of April 25, 2018

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of MiMedx Group Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of April 25, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of MiMedx Group Inc.

Oversold Conditions For MiMedx Group (MDXG)

Oversold Conditions For MiMedx Group (MDXG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In MiMedx Group, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In MiMedx Group, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

The Klein Law Firm Announces A Class Action Filed On Behalf Of MiMedx Group Inc. Shareholders And A Lead Plaintiff Deadline Of April 25, 2018

The Klein Law Firm Announces A Class Action Filed On Behalf Of MiMedx Group Inc. Shareholders And A Lead Plaintiff Deadline Of April 25, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of MiMedx Group Inc.